Serviço de psiquiatria e Saúde Mental de Adultos da ULSLO | Serviço de Segurança e Saúde no trabalho da ULSLO
Lisbon, Lisbon District, 1349-019, Portugal
NCT Number: NCT07765121
This single-arm, before-after study evaluated the feasibility of ViaMente, a nurse-led psychotherapeutic group programme designed to reduce burnout and promote psychological well-being in mental healthcare professionals. Grounded in nursing theory, the programme comprised five weekly group sessions. Feasibility was assessed through recruitment, retention, and acceptability, alongside preliminary changes in burnout and psychological well-being measured before and after the intervention.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Lisbon, Lisbon District, 1349-019, Portugal
This single-arm, before-after feasibility study evaluated ViaMente, a nurse-led psychotherapeutic group programme (five weekly sessions, grounded in nursing theory) aimed at reducing burnout and promoting psychological well-being in mental healthcare professionals.
Feasibility was the primary focus, assessed through recruitment, retention, and acceptability. Retention was defined as completing the programme with no more than two absences across the five sessions.
Preliminary changes in burnout (CBI-PT) and psychological well-being (PGWB-S) were assessed at baseline and post-intervention. Given the feasibility purpose, single-arm non-randomised design, and small sample, the study was not designed to test efficacy but to inform a future, adequately powered study.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Nurse-led psychotherapeutic group programme comprising five weekly sessions grounded in nursing theory (Gottlieb, Peplau), targeting burnout recognition and management, time-organization strategies, stress reduction, and self-care practices, with the aim of reducing burnout and increasing psychological well-being.
Time frame: Week 5
Acceptability of the programme, rated on a 0-5 Likert scale, where 0 indicates the lowest acceptability and 5 the highest; higher scores indicate greater acceptability.
Time frame: Week 5
Retention rate, defined as the proportion of enrolled participants who completed the programme without exceeding the permitted number of absences (maximum of two absences across the five sessions). Assessed after the fifth session.
Time frame: Baseline and week 5
Change in burnout, measured by the Copenhagen Burnout Inventory - Portuguese version (CBI-PT). Score range 0-100; higher scores indicate greater burnout. A mean score ≥50 is conventionally interpreted as indicative of high (clinically relevant) burnout.
Time frame: Baseline and week 5
Change in psychological well-being, measured by the Psychological General Well-Being Index - short version (PGWB-S). Score range 0-30; higher scores indicate better psychological well-being. No established clinical cut-off.
Centro Hospitalar Lisboa Ocidental
Other Gov
A Single-Arm Before-After Feasibility Evaluation of ViaMente, a Nurse-Led Psychotherapeutic Group Programme for Burnout and Psychological Well-Being in Mental Healthcare Professionals
Acronym: ViaMente
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05677997
Behavior, Behavioral Symptoms
Toronto, Ontario, Canada
View Trial DetailsNCT07465809
Behavior, Behavioral Symptoms
Bratislava, Slovakia
View Trial DetailsNCT06014892
Behavior, Behavioral Symptoms
Boston, Massachusetts, United States
View Trial DetailsNCT05658068
Behavior, Behavioral Symptoms
New York, United States
View Trial Details